Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Garbe

Showing results (211-220 of 501) with videos related to

Pageof 51
Sort By:
Cancers|August 7, 2021
Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin MelanomasMaximilian Gassenmaier, Matthias Hahn, Gisela Metzler, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2023
Sentinel lymph node biopsy for lentigo maligna melanoma under local anaesthesiaJulia Huynh, Ulrike Leiter, Claus Garbe, et al.
Expert Opinion on Biological Therapy|June 15, 2012
Management of pegylated interferon alpha toxicity in adjuvant therapy of melanomaAdil Daud, Christopher Soon, Reinhard Dummer, et al.
Plos One|January 26, 2012
Prognosis of sentinel node staged patients with primary cutaneous melanomaOtmar Elsaesser, Ulrike Leiter, Petra G Buettner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2020
Influence of <sup>18</sup>F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approachSusann-Cathrin Olthof, Andrea Forschner, Peter Martus, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2020
Prognostic significance of an 11-gene RNA assay in archival tissue of cutaneous melanoma stage I-III patientsThilo Gambichler, Konstantinos Tsagoudis, Felix Kiecker, et al.
Oncotarget|April 19, 2017
Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinaseCorinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, et al.
European Radiology|October 19, 2016
Imaging of gastrointestinal melanoma metastases: Correlation with surgery and histopathology of resected specimenAhmed E Othman, Thomas K Eigentler, Georg Bier, et al.
Experimental Dermatology|April 20, 2017
Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1Heike Niessner, Corinna Kosnopfel, Tobias Sinnberg, et al.
Oncotargets and Therapy|June 26, 2020
Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors - Results of a Prospective Biomarker StudyAndrea Forschner, Stephanie Weißgraeber, Dirk Hadaschik, et al.
Pageof 51

Showing results (211-220 of 501) with videos related to

Sort By:
Pageof 51
Cancers|August 7, 2021
Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin MelanomasMaximilian Gassenmaier, Matthias Hahn, Gisela Metzler, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2023
Sentinel lymph node biopsy for lentigo maligna melanoma under local anaesthesiaJulia Huynh, Ulrike Leiter, Claus Garbe, et al.
Expert Opinion on Biological Therapy|June 15, 2012
Management of pegylated interferon alpha toxicity in adjuvant therapy of melanomaAdil Daud, Christopher Soon, Reinhard Dummer, et al.
Plos One|January 26, 2012
Prognosis of sentinel node staged patients with primary cutaneous melanomaOtmar Elsaesser, Ulrike Leiter, Petra G Buettner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2020
Influence of <sup>18</sup>F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approachSusann-Cathrin Olthof, Andrea Forschner, Peter Martus, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2020
Prognostic significance of an 11-gene RNA assay in archival tissue of cutaneous melanoma stage I-III patientsThilo Gambichler, Konstantinos Tsagoudis, Felix Kiecker, et al.
Oncotarget|April 19, 2017
Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinaseCorinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, et al.
European Radiology|October 19, 2016
Imaging of gastrointestinal melanoma metastases: Correlation with surgery and histopathology of resected specimenAhmed E Othman, Thomas K Eigentler, Georg Bier, et al.
Experimental Dermatology|April 20, 2017
Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1Heike Niessner, Corinna Kosnopfel, Tobias Sinnberg, et al.
Oncotargets and Therapy|June 26, 2020
Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors - Results of a Prospective Biomarker StudyAndrea Forschner, Stephanie Weißgraeber, Dirk Hadaschik, et al.
Pageof 51